BRCA2 pathogenic variants localized in 5’ (5’ to c.2830) and 3’ (3’ to c.6402) regions were associated with a significant higher breast cancer risk compared with pathogenic variants within the central region [12]. The gene discussed is BRCA2; the disease is breast carcinoma.